Assessment of fluoxetine in stroke recovery trial Lead PI: Prof Graeme J Hankey and A/Prof Maree L. Hackett Status: Closed No….
Past Trials
A Phase 1b/2, Multi-Centre, Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in…
A Very Early Rehabilitation Trial AVERT is a Phase III, international, multicentre, single blind trial comparing earlier onset and higher…
Constraint Induced or Multi-Modal aphasia rehabilitation: A Randomised Controlled Trial (RCT) for stroke related chronic aphasia Lead PI: A/Prof Miranda Rose Status: Completed…
A Multicentre, Randomised, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects…
Extending the time for Thrombolysis in Emergency Neurological Deficits Phase III, randomised, multicentre, double blinded, placebo controlled trial (2 arm…
Extending the time for thrombolysis in emergency neurological deficits – intra-arterial with tenecteplase Lead PI: Dr Bruce Campbell Status: Closed No. of…
Determining the Optimal Dose of Tenecteplase Before Endovacular Therapy for Ischaemic Stoke (EXTEND-IA TNK Part 2) Lead PI: Dr Bruce Campbell…
INternational Stroke Perfusion Imaging Registry INSPIRE: INternational Stroke Perfusion Imaging REgistry Lead PI: John Hunter Hospital Status: Closed No. of Patients…
A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of…